Intravenous nicardipine in the treatment of postoperative arterial hypertension

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 11, Issue 2, 1997, Pages 160-164

  Vincent, Jean Louis ^a   Berlot, Giorgio ^a   Preiser, Jean Charles ^a   Engelman, Edgard ^a   Dereume, Jean Pierre ^a   Khan, Robert J ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

aortic aneurism; arterial oxygen tension; calcium entry blockers; hypertension; oxygen consumption; oxygen delivery; venous admixture

Indexed keywords

NICARDIPINE;

ABDOMINAL AORTA ANEURYSM; ADULT; AGED; ARTERIAL OXYGEN TENSION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEART INDEX; HEART MUSCLE ISCHEMIA; HUMAN; HYPERTENSION; INTRAVENOUS DRUG ADMINISTRATION; LUNG EDEMA; MALE; MEAN ARTERIAL PRESSURE; OXYGEN CONSUMPTION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SYSTEMIC VASCULAR RESISTANCE;

EID: 0030899182     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-0770(97)90206-8     Document Type: Article

References (37)

1. Coriat P, Rossignon MD, Montejo LS: Interest in calcium channel blockers during the perioperative period, in Vincent JL (ed): Update 1988 - Update in Intensive Care and Emergency Medicine - 5. New York, NY, Springer Verlag, 1988, pp 341-348
2. Kaplan JA: Clinical considerations for the use of intravenous nicardipine in the treatment of postoperative hypertension. Am Heart J 119:443-446, 1990
3. Koolen JJ, Van Wezel HB, Visser CA, et al: Nicardipine for preservation of myocardial metabolism and function in patients undergoing coronary artery surgery. Anesthesiology 71:508-518, 1989
4. Hano O, Silverman HS, Blank PS, et al: Nicardipine prevents calcium loading and "oxygen paradox" in anoxic single rat myocytes by a mechanism independent of calcium channel blockade. Circ Res 69:1500-1505, 1991
5. Sorkin EM, Clissold SP, Brogden RN: Nicardipine: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders. Drugs 30:182-274, 1985
6. Goldberg ME, Clark S, Joseph J, et al: Nicardipine versus placebo for the treatment of postoperative hypertension. Am Heart J 119:446-450, 1990
7. Halpern NA, Goldberg M, Neely C, et al: Postoperative hypertension: A multicenter prospective, randomized comparison between intravenous nicardipine and sodium nitroprusside. Crit Care Med 20:1637-1643, 1992
8. IV Nicardipine Study Group: Efficacy and safety of intravenous nicardipine in the control of postoperative hypertension. Chest 99:393-398, 1991
9. Abe K, Iwanaga H, Shimada Y, Yoshiya I: The effect of nicardipine on carotid blood flow velocity, local cerebral blood flow, and carbon dioxide reactivity during cerebral aneurysm surgery. Anesth Analg 76:1227-1233, 1993
10. Begon C, Dartayet B, Edouard A, et al: Intravenous nicardipine for treatment of intraoperative hypertension during abdominal surgery. J Cardiothorac Anesth 3:707-711, 1989
11. Bernard JM, Pinaud M, François T, et al: Deliberate hypotension with nicardipine or nitroprusside during total hip arthroplasty. Anesth Analg 73:341-345, 1991
12. Packer M: Second generation calcium channel blockers in the treatment of chronic heart failure: Are they any better than their predecessors? J Am Coll Cardiol 14:1339-1342, 1989
13. Aroney CN, Semigran MJ, Dec GW, et al: Left ventricular diastolic function in patients with left ventricular systolic dysfunction due to coronary artery disease and effect of nicardipine. Am J Cardiol 67:823-829, 1991
14. Simonneau G, Escourrou P, Duroux P: Inhibition of hypoxic pulmonary vasoconstriction by nifedipine. N Engl J Med 304:1582-1589, 1981
15. Johnston WE, Vinten-Johansen, J, Tommasi E: Effect of nifedipine on oxygen delivery in canine asymetric oleic acid lung injury. Crit Care Med 18:738-743, 1990
16. Melot C, Hallemans R, Naeije R: Deleterious effect of nifedipine on pulmonary gas exchange in chronic obstructive pulmonary disease. Am Rev Respir Dis 130:612-617, 1984
17. Vincent JL, N'Guyen M, Leon M, et al: Automated cardiovascular analysis and treatment (ACAT). Int J Clin Monit Comput 6:181-183, 1989
18. Daper A, Parquier JN, Preiser JC, et al: Timing of cardiac output measurements during mechanical ventilation. Acute Care 12:113-116, 1989
19. Robin ED, McCauley R: Nitroprusside-related cyanide poisoning: Time (long past due) for urgent, effective interventions. Chest 102:1842-1845, 1992
20. Lambert CR, Hill JA, Feldman RL, Pepine CJ: Effects of nicardipine on left ventricular function and energetics in man. Int J Cardiol 10:237-249, 1986
21. Lambert CR, Grady T, Hashimi W, et al: Hemodynamic and angiographic comparison of intravenous nitroglycerin and nicardipine mainly in subjects without coronary artery disease. Am J Cardiol 71:420-423, 1993
22. Burlew BS, Gheorghiade M, Jafri SM, et al: Acute and chronic hemodynamic effects of nicardipine hydrochloride in patients with heart failure. Am Heart J 114:793-804, 1987
23. Ryman KS, Kubo SH, Lystash J, et al: Effect of nicardipine on rest and exercise hemodynamics in chronic congestive heart failure. Am J Cardiol 58:583-588, 1986
24. Silke B, Verma SP, Nelson GI, et al: Haemodynamic dose-response effects of IV nicardipine in coronary artery disease. Br J Clin Pharmacol 18:717-724, 1984
25. Lambert CR, Pepine CJ: Effects of intravenous and intracoronary nicardipine. Am J Cardiol 64:8H-15H, 1989
26. Ogawa T, Sekiguchi T, Ishii M, et al: Acute effects of intravenous nicardipine on hemodynamics and cardiac function in patients with a healed myocardial infarction and no evidence of congestive heart failure. Am J Cardiol 68:301-305, 1991
27. Waters D: Proischemic complications of dihydropyridine calcium channel blockers. Circulation 84:2598-2600, 1991
28. Kennedy T, Summer W: Inhibition of hypoxic pulmonary vasoconstriction by nifedipine. Am J Cardiol 50:864-869, 1982
29. Redding GJ, Tuck R, Escourrou P: Nifedipine attenuates acute hypoxic pulmonary vasoconstriction in awake piglets. Am Rev Respir Dis 129:785-789, 1984
30. Stanbrook HS, Morris KG, McMurtry IF: Prevention and reversal of hypoxic pulmonary hypertension by calcium antagonists. Am Rev Respir Dis 130:81-86, 1984
31. Packer M, Medina N, Yushak M: Adverse hemodynamic and clinical effects of calcium channel blockade in pulmonary hypertension secondary to obliterative pulmonary vascular diseases. J Am Coll Cardiol 4:890-896, 1984
32. Kalra L, Bone MF: Effect of nifedipine on physiologic shunting and oxygenation in chronic obstructive pulmonary disease. Am J Med 94:419-423, 1993
33. Benumof JL: Hypoxic pulmonary vasoconstriction and infusion of sodium nitroprusside. Anesthesiology 50:481-483, 1979
34. Vincent JL, Lignian H, Gillet JB, et al: Increase in PaO2 following intravenous administration of propranolol in acutely hypoxemic patients. Chest 88:558-562, 1985
35. Saadjian A, Philip-Joët F, Hot B, et al: Effects of nicardipine on pulmonary and systemic vascular reactivity to oxygen in patients with pulmonary hypertension secondary to chronic obstructive lung disease. J Cardiovasc Pharmacol 17:731-737, 1991
36. Vincent JL, Goldstein J, Dufaye P, Domb M: Electromechanical dissociation after ventricular fibrillation: Prevention with calcium entry blockers. J Cardiovasc Pharmacol 6:1124-1131, 1984
37. Vincent JL, Roman A, DeBacker D, Kahn RJ: Oxygen uptake/ supply dependency: Effects of short-term dobutamine infusion. Am Rev Respir Dis 142:2-8, 1990